Is India Winning the War Against Rising Non-Communicable Diseases? The latest health statistics paint a concerning picture: diabetes, heart disease, and cancer rates are climbing, impacting millions across the country. From rural healthcare access to the burgeoning urban health crisis, challenges remain significant. This week, we delve into the crucial initiatives underway – government policies, technological advancements in telemedicine, and the rising role of preventative healthcare – that aim to address this national health emergency. Experts weigh in on the effectiveness of current strategies and the critical need for increased public awareness campaigns targeting lifestyle diseases. Are these efforts enough? Explore Abtak.com's in-depth coverage on healthcare in India and discover the vital information you need to protect your well-being and the future of public health. Stay informed; stay healthy.
New Delhi, Oct 1 (PTI) Drug maker Lupin on Wednesday said it has launched an anticoagulant medication in the US. The company has launched Rivaroxaban for Oral Suspension (1 mg/mL), a generic version of Janssen Pharmaceuticals, Inc.'s Xarelto for Oral Suspension, in the US, the drug maker said in a statement. Rivaroxaban for Oral Suspension is indicated for the treatment of venous thromboembolism (VTE) and the reduction in the risk of recurrent VTE in pediatric patients. It is also indicated for the treatment of thromboprophylaxis in pediatric patients 2 years and older with congenital heart disease after the Fontan procedure. As per IQVIA MAT July 2025 data, Rivaroxaban for Oral Suspension, 1 mg/mL, had estimated annual sales of USD 11 million in the US. PTI MSS MSS SHW SHW
India's pharmaceutical industry, valued at $50 billion, is booming as a global leader in generic drugs. With significant exports to 200+ countries, India meets a substantial portion of global demand for affordable medicine. Challenges include regulatory hurdles and quality assurance, as the nation aims to expand its generic drug market. The Indian pharmaceutical industry, currently valued at $50 billion, is playing an increasingly crucial role on the global stage. Renowned as the 'pharmacy of the world,' India's pharma sector is a major exporter, supplying essential generic drugs to over 200 ...Read More >
HÀ NỘI While more than half of people living with rare diseases in Việt Nam are children, access to rare disease treatment remains limited due to high costs and a lack of comprehensive health insurance coverage. According to the Ministry of Health, Việt Nam has about six million people living with rare diseases, 58 per cent of whom are children. Data shows that an alarming 30 per cent of children with rare diseases die before the age of five. Rare diseases often include metabolic disord ...Read More >
New Delhi: With the cent percent tariff imposed by the US on imports of branded and patented pharmaceutical drugs, starting October 1, 2025 across the board, including India, New Delhi on Friday did not react officially though, the government, however, is confident that India will continue to engage with the US officials even after the meeting held from September 22-24, and a decision to roll back -- either fully or partially -- on such 'hefty' tariff, especially on pharma products, is expected soon, a top source privy to development said. "We are not at all disturbed with the 'harsh' decisio ...Read More >
New Delhi [India], October 8 (ANI): The Federation of All India Medical Association (FAIMA) has expressed serious concern over the reported deaths of children in Madhya Pradesh linked to the consumption of a particular cough syrup. In a letter to the Union Health Minister on Wednesday, the association stated that the incident raised serious questions about the safety, quality assurance, and monitoring mechanisms governing the manufacture and distribution of pharmaceutical products for children. FAIMA requested to constitute a Central Investigation Committee under the Ministry to conduct a de ...Read More >
Mumbai: Dr Reddy's Laboratories has entered into a collaboration with Reykjavik, Ireland-based biotech company Alvotech to co-develop, manufacture and commercialise a biosimilar version of blockbuster cancer drug Keytruda for the global markets. Keytruda (generic name is pembrolizumab), manufactured and marketed by Merck & Co, is the most successful medicine, recording worldwide sales of $29.5 billion in 2024. It is used to treat multiple forms of cancer. Under the terms of the agreement, both companies will be jointly responsible for developing and manufacturing the biosimilar candidate and ...Read More >
New Delhi: Chief minister Rekha Gupta on Sunday said authorities cannot go against demolition orders issued by courts and stressed that displaced residents have been provided accommodation.Her words came in the wake of the recent Madrasi Camp demolition for which the opposition Aam Aadmi Party (AAP) has criticised her. AAP has targeted Gupta, and alleged that the displaced Madrasi Camp residents were provided homes in faraway Narela, and those lack basic amenities.Attending an event to mark the construction of a Jan Sewa camp at a slum cluster in the Haiderpur area, Gupta told reporters: "In t ...Read More >
New Delhi [India], July 14 (ANI): Opening India's dairy sector to US imports could result in an annual loss of Rs 1.03 lakh crore to Indian dairy farmers, according to a recent report by the State Bank of India (SBI). The report cautioned that the move would significantly impact the livelihoods of small dairy farmers, as the US dairy sector is heavily subsidized. Also Read | Bitcoin Price Hits All-Time High Today, Cryptocurrency Surpasses USD 1,21,000 Mark for First Time. SBI stated, "If the dairy sector is opened up, price of milk in India is likely to drop by at least 15 per cent which co ...Read More >
Chandigarh: Officials of Municipal Corporation Chandigarh have revealed that the top 20 property tax defaulters of the city are yet to clear dues of over Rs 190 crore, while property tax arrear cases worth Rs 62 crore are under litigation in the Punjab and Haryana high court. Citing different reasons, occupants of seven properties, out of the top 20, have challenged the MC's arrears amount, following which the authority failed to recover the amount from them. All these properties fall under the commercial category. As per official data of the Municipal Corporation, Chandigarh, commercial prope ...Read More >
New Delhi [India], August 14 (ANI): India's overall trade deficit (merchandise and services combined) widened to USD 11.72 billion in July 2025, up from USD 10.10 billion in the same month last year, driven by a sharper rise in imports than exports, according to the data released by the Commerce & Industry Ministry.The data shows that the overall exports stood at USD 68.25 billion in July 2025, marking a growth from the same month of the previous year at USD 65.31 billion.On the other hand, imports of the country grew at a faster pace, reaching USD 79.99 billion compared with USD 75.41 billion ...Read More >
New Delhi, Aug 1 (PTI) Commerce and Industry Minister Piyush Goyal will hold meetings with exporters from different sectors, including food processing, textiles, engineering, and chemicals, from August 2-4 in Mumbai to discuss the implications of 25 per cent tariff announced by the US, an industry official said on Friday. The official added that exporters from segments such as fisheries, engineering, IT, and pharma will also participate in the deliberations. Leather sector exporters are expected to meet the minister on August 4 here. The US on Friday slapped a 25 per cent tariff on India, p ...Read More >
New Delhi, Sep 15 (SocialNews.XYZ) India's total exports of merchandise and services clocked a robust growth of 9.34 per cent in August to $69.16 billion compared to the same month of the previous year, according to official figures released by the Commerce and Industry Ministry on Monday. The country's merchandise exports during August 2025 went up to $35.10 billion as compared to $32.89 billion in August 2024 despite the economic uncertainties in the global market triggered by the US tariff hike. "Despite global uncertainties and trade policy uncertainties, Indian exporters have done well. ...Read More >
New Delhi, Sep 26 (PTI) Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Reacting to the development, IPA Secretary General Sudarshan Jain said in a statement, "It is not applicable to generics medicines." Trump's statement refers to patented and branded products supplied to US, he added. In his post on social media platform Truth Social, Trump wrote, "Starting October 1st, 2025, we will be imposing a 100% Tari ...Read More >
New Delhi: US President Donald Trump's decision to impose 100% tariffs on branded and patented drug exports has shaken Indian pharmaceutical markets, despite most of India's $10 billion US sales being in generics. The uncertainty lies in whether complex generics and specialty medicines will be included, a move that could directly impact leading players like Sun Pharma, Dr. Reddy's, Cipla, Zydus Lifesciences, and others. Stocks Facing Highest Exposure Dr. Reddy's emerges as the most vulnerable, with 47% of its earnings tied to the US market, projected at $1.5 billion in FY26. Sun Pharma follo ...Read More >
Ministry of External Affairs (MEA) Official Spokesperson Randhir Jaiswal, reacting to US President Donald Trump's imposition of 100% tariffs on imports of branded and patented pharmaceutical drugs from October 1, 2025, said the government is monitoring the situation closely. On Thursday, the Trump administration announced that starting October 1, 2025, it will be imposing a 100% tariff on any branded or patented pharmaceutical product, unless a company is building their pharmaceutical manufacturing plant in America. Experts say Trump's decision is unlikely to have a significant impact on the ...Read More >
Ahmedabad: Indian Institute of Public Health in Gandhinagar (IIPH-G) in collaboration with state-based endocrinologists will map the prevalence of Type 1 diabetes in Gujarat in a longitudinal study. The project, announced on Monday, will be a ten-year long study and will be one of the biggest to explore various aspects of the condition including comorbidities, mortality, and rural vs urban divide, among others.Dr Komal Shah, lead, NCD Advocacy and Research Collaboration (NCDArc) Centre at IIPH-G, said that a stakeholders' meeting was held on Monday with participation from state education and s ...Read More >
New Delhi [India], August 14 (ANI): India overall trade deficit (merchandise and services combined) widened to USD 11.72 billion in July 2025, up from USD 10.10 billion in the same month last year, driven by a sharper rise in imports than exports, according to the data released by the Commerce & Industry Ministry. The data shows that the overall exports stood at USD 68.25 billion in July 2025, marking a growth from the same month of the previous year at USD 65.31 billion. On the other hand, imports of the country grew at a faster pace, reaching USD 79.99 billion compared with USD 75.41 billi ...Read More >
Nitin Gadkari envisions India transforming into a global energy exporter by reducing hydrogen production costs to $1 per kg, emphasizing its potential in transport, pharmaceuticals, and steel. He highlighted the importance of waste management for green hydrogen production and advocated for electric vehicles, biofuels, and bamboo cultivation to achieve carbon neutrality and self-reliance. Road Transport and Highways Minister Nitin Gadkari on Wednesday said India can transform from being an energy ...Read More >
Mumbai, September 26: The Indian benchmark indices opened lower on Friday, following US President Donald Trump's announcement of tariffs on pharma imports and sustained selling by foreign institutional investors. As of 9.25 am, Sensex was down 388 points, or 0.48 per cent at 80,771 and Nifty was down 119 points, or 0.48 per cent at 24,771. Shares of Indian and other Asian pharmaceutical companies fell after Trump announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical drugs, starting October 1, 2025. Apart from drugs, President Trump announced a 50 per cent d ...Read More >
New Delhi [India], September 26 (ANI): India's pharmaceutical exports are not expected to face a major impact following the recent announcement of a 100 per cent tariff on branded and patented pharmaceutical products by the US, said Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance (IPA). Speaking to ANI on Friday, Jain said that India's exports to the US primarily consist of generic drugs and active pharmaceutical ingredients (APIs), which are not covered under this tariff. "This [100 per cent tariff on imported pharmaceutical drugs] is applicable to patented branded p ...Read More >
For the month, FII sold equities worth Rs 30,141.68 crore, while DII bought equities worth Rs 55,736.09 crore. The broader indices broke a three-week gaining streak and underperformed the main indices as markets remained under pressure throughout the week on worries over fresh tariffs on pharma, higher visa fees by the US, persistent trade concerns, and continued FII selling. For the week, Nifty50 plunged 672.35 points or 2.65 percent to finish at 24,654.70, while the BSE Sensex index declined ...Read More >
"Currently, there are around 800 medical device manufacturers in the country, and India's annual growth of the Medtech sector is 15 to 20 per cent," said Singh. Image: ANI India's pharma exports, currently valued at nearly USD 27.8 billion, are expected to cross $30 billion by the year-end, said Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh on Tuesday. Singh stated that India's domestic pharma market is $60 billion, but is expected to double, that is, $13 ...Read More >
New Delhi, Jan 21 (PTI) India and Belgium have agreed to establish mechanisms to resolve trade issues in areas such as pharma and agri products to boost bilateral trade, according to an official statement issued on Tuesday. The issues were discussed during the meeting between Commerce and Industry Minister Piyush Goyal and Belgian Minister of Foreign Affairs and Foreign Trade Bernard Quintin, in Brussels. "Regulatory barriers, particularly in the approval processes for pharmaceuticals and agri-products, were also discussed, with both sides agreeing to tackle these challenges through continuo ...Read More >
New Delhi, Jun 30 (PTI) Torrent Pharmaceuticals expects the Rs 19,500-crore deal to acquire majority stake in Mumbai-based J B Chemicals and Pharmaceuticals to complete over the next 15-18 months. As per the deal, which is the second largest in the domestic pharmaceutical space behind Sun Pharma's 2015 acquisition of Ranbaxy, Torrent will acquire 46.39 per cent stake from promoters Tau Investment Holdings Pte Ltd (a unit of global investment firm) for about Rs 11,917 crore. It would additionally buy another 2.80 per cent from certain employees of JB Chemicals at the same acquisition price of ...Read More >
New Delhi [India], September 15 (ANI): India is set to host an AI Impact Summit come February 2026, that will follow the previous summit in France, Union Minister for Electronics and IT Ashwini Vaishnaw said Monday. Prime Minister Narendra Modi had attended in person the Summit in France Paris, which he jointly co-chaired. The upcoming summit, as the name suggests, will focus on the safety and impact of AI. In preparation for this event, NITI Aayog organized a gathering to showcase and share best practices of AI applications across various districts in India, the Union Minister apprised rep ...Read More >
New Delhi, Sep 26 (PTI) India and the US have decided to continue negotiations for early conclusion of a mutually beneficial bilateral trade agreement, the Commerce Ministry said on Friday. The statement was issued after the return of the Indian official delegation led by Commerce and Industry Minister Piyush Goyal to New York for trade talks. The delegation returned on September 24 after holding three-day talks. Both sides held constructive meetings on various aspects of the trade deal, the ministry said in a statement. "Both sides exchanged views on possible contours of the deal, and it ...Read More >
Ahmedabad (Gujarat) [India], September 29: As India observes World Heart Day, the conversation around cardiovascular health has once again turned to prevention, timely treatment, and most importantly, access to affordable medicines for everyone. Heart disease remains the leading cause of death in India at 28.1%, with more than half a billion people affected by a heart ailment. While treatment protocols have advanced, the cost of long-term medication continues to be a burden for many families. More so if one takes into account the fact that almost half of them cannot afford the medication. Als ...Read More >
The World Health Organization is seeking details from India regarding a cough syrup linked to child deaths. Several Indian states have banned the 'Coldrif' syrup. Lab reports confirmed it contained a toxic industrial solvent. A criminal case has been registered against the manufacturer, Sresan Pharma. The doctor who prescribed the syrup has been arrested. The World Health Organization on Wednesday sought clarification from Indian authorities on whether a cough syrup linked to deaths of children ...Read More >
India and the European Union are advancing free trade agreement negotiations. Key tariff issues are seeing good progress. An EU delegation will visit New Delhi soon to finalize technical tariff discussions. Both sides aim for a robust and balanced agreement. This pact is expected to bring the economies closer and foster mutual benefits. Commerce and industry minister Piyush Goyal Tuesday said his talks with the EU have "significantly reduced our outstanding issues" and laid the foundation for a ...Read More >
New Delhi, Dec 17 (PTI) Drug firm Granules India on Tuesday said its subsidiary has received approval from the US health regulator for a generic medication used to treat attention-deficit hyperactivity disorder. Granules Pharmaceuticals, Inc (GPI) has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lisdexamfetamine Dimesylate chewable tablets, the drug firm said in a statement. The approved drug is available in multiple strengths; 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg, it added. The company's product is the generic ...Read More >
New Delhi: India's goods exports in June fell a tad from a year earlier, but a sharper drop in imports aided the trade deficit to narrow to a four-month low. Exports reduced 0.05% year-on-year to $35.14 billion, a seven month low, while imports fell 3.71% to $53.92 billion, leaving a trade deficit of $18.78 billion compared with $20.84 billion in June last year. Exports to the US in the past month rose sharply to $25.52 billion from $20.89 billion, despite the base tariff on Indian goods shippe ...Read More >